1 / 49100%
Accounting for Intangible Assets: Recognition, Measurement, Impairment
Testing, and Disclosure Requirements under ASC 350 and IAS 38
Introduction
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Intangible assets such as brands, patents, software, and customer relationships increasingly
drive value creation for knowledge-based companies. However, their identification and
accounting requires specialized application of standards due to intangibles' inherent
subjectivity and lack of physical existence. FASB's ASC 350, Intangibles - Goodwill and
Other, and IASB's IAS 38, Intangible Assets, provide authoritative guidance on accounting
policies and impairment testing for these important assets.
This report examines key aspects of intangible asset accounting according to U.S. GAAP and
IFRS including recognition criteria, measurement approaches, ongoing impairment
assessment, and disclosure requirements. Adhering to consistent accounting strengthens
financial reporting transparency and performance benchmarking for assets contributing
significant economic benefits to entities.
Recognition Criteria
Recognition involves determining whether an item meets the definition of an intangible asset
and should be recorded separately from goodwill. Both ASC 350 and IAS 38 define an
intangible asset as an identifiable non-monetary asset without physical substance held for use
in the business.
Key criteria for separate recognition from goodwill include:
- Asset is identifiable due to being separable or arising from contractual/legal rights
- Future economic benefits are probable from use or sale of the asset
- Cost can be measured reliably
Examples meeting recognition requirements include brands, patents, trademarks, software,
customer/supplier relationships, non-compete agreements. Internally developed intangibles
also qualify if certain development stage criteria are met.
Initial Measurement
Upon recognition, intangible assets are initially measured at cost. Entities must determine
whether the asset was acquired externally or internally developed.
Purchased intangibles cost includes acquisition price and other costs directly attributable to
preparing the asset for intended use. Examples include broker/attorney fees and valuation
costs.
Developed intangibles require capitalizing internal/external costs during the development
phase like materials/labor and design/testing activities. Subsequent expenditures maintain or
improve existing assets but do not qualify as the assets themselves.
Subsequent Measurement
After initial recognition, intangible assets lacking determinable useful lives are not amortized
and are subject to annual impairment testing. Examples include indefinite-lived brands.
Intangible assets with finite useful lives are amortized over their estimated periods.
Amortization methods follow the asset's pattern of economic benefit consumption or a
straight-line basis if indeterminable. Estimates require judgment balanced with prudence.
Additionally, impairment indicators like significant underperformance versus plan, asset
removal/replacement trigger interim reviews between annual tests. Adjustments are made for
any impairment losses determined necessary.
Impairment Testing
Annually and as indicators arise, entities assess intangible asset carrying values for
impairment according to ASC 350 and IAS 36 principles. A two-step approach compares the
asset's carrying amount against its recoverable amount defined as the higher of value in use or
fair value less costs of disposal.
Value in use utilizes discounted future cash flows incorporating reasonable, supportable
assumptions around revenue growth, costs, capital needs, and discount/terminal growth rates.
Fair value relies on market prices or valuation techniques like discounted cash flows from a
market participant perspective.
Losses occur when carrying values exceed respective recoverable amounts, requiring write-
downs through profit or loss. Intangible assets may also face increased risk of obsolescence
due to technological changes. Entities actively evaluate economic lives and test for
impairment.
Disclosure Requirements
Both ASC 350 and IAS 38 mandate extensive financial statement note disclosures addressing
intangible asset categories, useful lives, valuation techniques, impairment test methodology,
and significant assumptions/sensitivities.
Rollforwards reconcile beginning and ending carrying amounts. Unrecognized intangible
assets like research/development costs provide transparency while avoid potential
overstatement. Clear, principles-based disclosure supports informed economic decision
making.
Robust accounting and governance around intangible assets communicates accurate
representation of these strategic drivers of value while adhering to GAAP requirements and
consistency across reporting periods. Overall, following IFRS and ASC guidance strengthens
financial reporting integrity for complex asset types.
Practical Application
Consider a biotech company granted Patents for novel cancer therapies and Rights to
distribution networks upon acquisition of competitors.
The Patents meet criteria for initial capitalization at legal/application fees as costs to ready
assets for use. Rights will record at fair value as part of purchase price allocation.
Useful lives for both require judgment based on legal, technical or economic obsolescence
expectations. Patents may amortize over 17 years while relationships potentially indefinite
due to attrition risk analysis.
Annual impairment reviews discount cash flow projections from approved budgets/forecasts
at rates reflecting asset-specific risks. Sensitivity testing explores impacts of alternative
assumptions.
Notes disclose categories, carry values, lives, valuation policies and reconciliation schedules
adhering to principles of transparency and consistency across periods. Overall accounting
supports performance evaluation and compliance.
Conclusion
Specialized accounting principles govern recognition, measurement and impairment testing
for strategic intangible assets. Adherence to ASC 350, IAS 38 and disclosure requirements
provides transparency into these value drivers' contribution and risk profile. Robust policies
around estimations and impairment assessments strengthen financial reporting quality amid
such assets' inherently subjective nature. Ongoing evaluation keeps pace with economic life
expectancy changes to intangibles amid technological advancement and competitive
disruption. Overall accounting standards facilitate meaningful benchmarking and decision
making regarding invisible assets growing firms' capabilities for creating long term value.
Students also viewed